María Jesús Lloret

798 total citations
27 papers, 478 citations indexed

About

María Jesús Lloret is a scholar working on Nephrology, Nutrition and Dietetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, María Jesús Lloret has authored 27 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 9 papers in Nutrition and Dietetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in María Jesús Lloret's work include Parathyroid Disorders and Treatments (17 papers), Magnesium in Health and Disease (8 papers) and Bone health and treatments (4 papers). María Jesús Lloret is often cited by papers focused on Parathyroid Disorders and Treatments (17 papers), Magnesium in Health and Disease (8 papers) and Bone health and treatments (4 papers). María Jesús Lloret collaborates with scholars based in Spain, France and United Kingdom. María Jesús Lloret's co-authors include Jordi Bover, Felipe Vilella, Lyle Armstrong, Stuart P. Atkinson, Majlinda Lako, José Ballarín, José-María Sánchez-Puelles, María Teresa Calvo, Francisco Javier Rodríguez-Jiménez and Slaven Erceg and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Stem Cells.

In The Last Decade

María Jesús Lloret

26 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Jesús Lloret Spain 11 175 151 103 83 70 27 478
Gaetano Desina Italy 8 213 1.2× 24 0.2× 107 1.0× 59 0.7× 32 0.5× 10 502
Fernando Neria Spain 11 192 1.1× 61 0.4× 23 0.2× 15 0.2× 41 0.6× 32 369
Maki Kabara Japan 13 177 1.0× 47 0.3× 42 0.4× 14 0.2× 33 0.5× 28 400
Yanwu You China 13 163 0.9× 74 0.5× 17 0.2× 57 0.7× 57 0.8× 34 430
Ying Yao China 14 462 2.6× 55 0.4× 98 1.0× 15 0.2× 15 0.2× 37 738
Jean‐Luc Carré France 11 82 0.5× 27 0.2× 14 0.1× 41 0.5× 30 0.4× 24 349
Sarah Bruneau France 14 154 0.9× 174 1.2× 44 0.4× 4 0.0× 47 0.7× 33 530
HN Nagaraja United States 6 54 0.3× 126 0.8× 55 0.5× 15 0.2× 143 2.0× 8 451
Tina K. Nguyen United States 6 121 0.7× 38 0.3× 339 3.3× 21 0.3× 34 0.5× 7 557

Countries citing papers authored by María Jesús Lloret

Since Specialization
Citations

This map shows the geographic impact of María Jesús Lloret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Jesús Lloret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Jesús Lloret more than expected).

Fields of papers citing papers by María Jesús Lloret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Jesús Lloret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Jesús Lloret. The network helps show where María Jesús Lloret may publish in the future.

Co-authorship network of co-authors of María Jesús Lloret

This figure shows the co-authorship network connecting the top 25 collaborators of María Jesús Lloret. A scholar is included among the top collaborators of María Jesús Lloret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Jesús Lloret. María Jesús Lloret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz‐Tocados, Juan Miguel, María Jesús Lloret, Alfonso Aranda, et al.. (2025). Magnesium Balance in Chronic Kidney Disease: Mineral Metabolism, Immunosuppressive Therapies and Sodium-Glucose Cotransporter 2 Inhibitors. International Journal of Molecular Sciences. 26(12). 5657–5657.
2.
Lloret, María Jesús, Maria Fusaro, Hanne Skou Jørgensen, et al.. (2024). Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter. Journal of Clinical Medicine. 13(4). 1010–1010. 8 indexed citations
3.
Belmar, Lara, Rosa Melero, Trinidad Serrano, et al.. (2024). Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: renal replacement therapy and mortality. FRA-COVID SEN Registry Data. Nefrología (English Edition). 44(4). 527–539. 1 indexed citations
4.
Lloret, María Jesús, Hanne Skou Jørgensen, & Pieter Evenepoel. (2024). Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?. Clinical Kidney Journal. 17(3). sfae048–sfae048. 1 indexed citations
5.
Jørgensen, Hanne Skou, María Jesús Lloret, Rukshana Shroff, et al.. (2024). Ten tips on how to assess bone health in patients with chronic kidney disease. Clinical Kidney Journal. 17(5). sfae093–sfae093. 3 indexed citations
6.
Belmar, Lara, Rosa Melero, María Luisa Serrano Salazar, et al.. (2023). Caracterización de la población con fracaso renal agudo durante la hospitalización por COVID-19 en España: tratamiento renal sustitutivo y mortalidad. Datos del Registro FRA-COVID SEN. SHILAP Revista de lepidopterología. 44(4). 527–539. 4 indexed citations
7.
Bover, Jordi, Pablo Molina, María Jesús Lloret, et al.. (2021). Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects. Frontiers in Medicine. 8. 642718–642718. 17 indexed citations
8.
Bover, Jordi, Pablo Ureña, Armando Torres, et al.. (2021). Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease. Nefrología (English Edition). 41(5). 514–528. 16 indexed citations
9.
Navarro‐González, Juan F., María Dolores Arenas, Fernando Henríquez, et al.. (2020). Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: the VELREAL multicentre study. Clinical Kidney Journal. 14(2). 681–687. 3 indexed citations
10.
Bover, Jordi, Pablo Ureña‐Torres, María Jesús Lloret, et al.. (2016). Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy. 17(9). 1247–1258. 20 indexed citations
11.
Bover, Jordi, José Luis Górriz, Pablo Ureña‐Torres, et al.. (2016). Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?. Nefrología (English Edition). 36(6). 587–596. 4 indexed citations
12.
Bover, Jordi, José Luis Górriz, Pablo Ureña‐Torres, et al.. (2016). Detección de las calcificaciones cardiovasculares: ¿una herramienta útil para el nefrólogo?. Nefrología. 36(6). 587–596. 10 indexed citations
13.
Bover, Jordi, Pablo Ureña‐Torres, José Luis Górriz, et al.. (2016). Calcificaciones cardiovasculares en la enfermedad renal crónica: Potenciales implicaciones terapéuticas. Nefrología. 36(6). 597–608. 19 indexed citations
14.
Bover, Jordi, Pablo Ureña‐Torres, María Jesús Lloret, et al.. (2016). Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification. Expert Opinion on Pharmacotherapy. 17(10). 1363–1373. 15 indexed citations
15.
Bover, Jordi, Pablo Ureña‐Torres, José Luis Górriz, et al.. (2016). Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications. Nefrología (English Edition). 36(6). 597–608. 3 indexed citations
16.
Bover, Jordi, Iara daSilva, Mónica Furlano, et al.. (2014). Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D<sub>2</sub> (Paricalcitol). Current Vascular Pharmacology. 12(2). 313–323. 10 indexed citations
17.
Fernández‐Llama, Patricia, et al.. (2012). Recombinant PTH associated with hypercalcaemia and renal failure: Table 1.. Clinical Kidney Journal. 6(1). 93–95. 5 indexed citations
18.
Bover, Jordi, et al.. (2009). Dietary and Pharmacological Control of Calcium and Phosphate Metabolism in Dialysis Patients. Blood Purification. 27(4). 369–386. 12 indexed citations
19.
Lloret, María Jesús, et al.. (2001). Utilidad de la colangiorresonancia magnética en el estudio de la enfermedad hepatobiliar en pacientes adultos con fibrosis quística. Gastroenterología y Hepatología. 24(3). 122–126. 3 indexed citations
20.
Acién, Pedro, et al.. (1990). Perinatal morbidity and mortality in pregnancy hypertensive disorders: prognostic value of the clinical and laboratory findings. International Journal of Gynecology & Obstetrics. 32(3). 229–235. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetano Desina Breakdown of academic impact, for papers by Fernando Neria Breakdown of academic impact, for papers by Maki Kabara Breakdown of academic impact, for papers by Yanwu You Breakdown of academic impact, for papers by Ying Yao Breakdown of academic impact, for papers by Jean‐Luc Carré Breakdown of academic impact, for papers by Sarah Bruneau Breakdown of academic impact, for papers by HN Nagaraja Breakdown of academic impact, for papers by Tina K. Nguyen
Rankless by CCL
2026